NAGLAZYME
Google image searchProduct monograph
Active ingredient
galsulfase, 1 MG/ML
DIN: 02412683
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: 5MG/5ML. SINGLE USE VIAL.
Schedule: Prescription / Schedule D
Company: BIOMARIN PHARMACEUTICAL INC.
Date: 01-JAN-2014
ATC:
- A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
- A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
- A16AB — Enzymes (ATC, ATC/DDD)
- A16AB08 — GALSUFASE (ATC/DDD)
Reference brand drug: Naglazyme
Pharmaceutical standard: MFR
